Biological Material Analysis TRIZ Cases

See how a conical through bore with arched edges provides extraction resistance to help paper s

On-chip spectral filters and ratiometric two-color detection cut drift and crosstalk for rapid picomolar cytokine sensing.

Solid phase extraction, HPLC, and high-resolution MS quantify insulin accurately without immunopurification in biological samples.

Variable-temperature charge-detection mass spectrometry separates AAV subpopulations by thermal stability to compare viral suspensions more precisely.

Ion mobility in the native state plus charge-reduced mass spectrometry resolves overlapping charge peaks to determine CCS for high-mass ions.

Differential compression of similar fluorescence signals cuts cloud transfer and storage load while preserving restoration of original flow cytometry data.

Differential encoding between similar fluorescence signals cuts flow cytometry data transfer time and cloud storage while preserving restorability.

Periodic source and gate voltages with lock-in detection help nanoscale FET sensors distinguish analyte binding in blood despite ionic noise.

Templated polymer pores with reintroduced reactive material enable rapid, low-cost, selective detection of drugs and toxic chemicals.

Ortholog-based mutant screening makes subtle protein activity changes detectable while limiting combinatorial overload in polypeptide evolution.

DNA aptamers with PGN-specific core sequences improve bacterial detection by minimizing LPS and LTA binding and separating Gram types.

Acridinium salt fluorescence enables rapid, quantitative cardiolipin binding assays with better probe stability, specificity, and screening throughput.

Click-chemistry HAT1 assays use alkyne acetyl donors and biotin labeling to find modulators that suppress tumor-promoting proliferation.

BC2LCN with SerpinA3 and Gal3BP assays improves early pancreatic cancer detection by raising blood-test sensitivity and specificity.

PD-L1 biomarker selection guides anti-PD-1 monotherapy in melanoma, extending progression-free survival with lower toxicity than combination therapy.

A 4A1 hybridoma antibody maps RABV M protein epitopes and distinguishes field strains from the Flury vaccine strain in diagnostic assays.

An ADAMTS13-binding antibody limits excessive VWF cleavage to help prevent bleeding complications during mechanical assisted circulation.

Factor VIII measurement guides personalized Xa inhibitor dosing to balance anticoagulation efficacy with lower bleeding risk.

Mannose-coated gold nanorods use a PEG-thiol linker to prevent aggregation and enable fast one-step MBL detection in undiluted serum.

Engineered spike-binding antibodies use defined CDR combinations to retain potent neutralization across emerging SARS-CoV-2 variants.

Permeabilized yeast cell walls let fluorescent ligands reach membrane GPCRs, enabling sorting and evolution of higher-expression variants.

Separate extraction and test chambers with tailored buffers enable simultaneous STI, pregnancy, and fertility detection while limiting cross-contamination.

Interaction modulators tune agglutination signals across analyte levels, extending immunoassay range without dilution while preserving sensitivity.

Humanized 31.1 antibodies target the A33 antigen to improve colon and pancreas cancer detection and support tumor-directed treatment.

Fluorescence imaging and morphology analysis cluster rare and common liquid biopsy cells without fixed phenotypes, improving diagnosis.

Radiolabeled anti-MET antibody conjugates enable precise PET visualization of MET expression to guide therapy selection and monitor tumor response.

By releasing bound and unbound magnetic particles near a sensor, this case improves analyte sensitivity without complex miniaturized layouts.

Multiple marker-binding phage capsids amplify lateral flow assay signals 25-70x, improving low-concentration biomolecule detection without extra hardware.

A bispecific single-domain antibody blocks both PD-L1/PD-1 and PD-L2/PD-1 interactions to reactivate T cells and counter tumor immune escape.

Antigen-specific co-culture of human immune cells avoids CpG-driven off-target antibodies while producing high-affinity c-met and TMX2 mAbs.

Specific TACI antibody binding enables measurement of free TACI or TACI-Fc levels to guide prognosis and therapy monitoring in autoimmune disease.

Droplet partitions and quenchbody fluorescence enable faster multiplexed antigen detection with higher sensitivity and no washing steps.

Specific MMP-1 antibodies enable simple immunoassay kits and test strips for sensitive oral cancer screening without complex instruments.

Humanized anti-B7H3 antibodies improve binding to free and cell-surface B7-H3, supporting more precise tumor diagnosis and treatment.

Epitope-specific antibodies bind defined hMPV F protein residues to neutralize the virus and support treatment or prevention of hMPV infection.

Immunochromatographic strips and a smartphone app quantify hemoglobin, CD45, and CD42b for home blood counts and telemedicine.

BMMF1 Rep protein detection with monoclonal antibodies improves early lung cancer risk stratification by linking tissue markers to chronic inflammation.

Bispecific LY6G6D and CD3 binding improves T-cell targeting of cancer cells, addressing limits of current colorectal cancer therapies.

Limited proteolysis with mass spectrometry measures drug-target residence time across native proteomes, improving efficacy prediction and off-target detection.

A mild 0.3 V potential at 35-42°C regenerates immunosensors by dissociating immunocomplexes while preserving sensitivity and specificity.

Time-division multiplexed spatial modulation lets optogenetic platforms activate and monitor multiple ROIs at high speed with synchronized DMD switching.

Behavioral zebrafish embryo data feeds prediction models to estimate whole wastewater toxicity faster, with fewer embryos and less testing time.

Targeted CDR sequence optimization improves CD157 binding specificity, signal-to-noise ratio, and blocking of CD157-mediated adhesion.

Lectin-binding glycosylation patterns in fPSA and CA19-9 improve discrimination of aggressive prostate cancer from benign conditions.

Conditional CD3 and CD123 binding helps kill CD123-expressing cancer cells while limiting T-cell activation and cytokine release syndrome.

Fully human CDR-defined antibodies bind conserved spike epitopes to retain potent neutralization against emerging SARS-CoV-2 variants.

Blocking CD73 on tumor cells cuts adenosine-driven immune suppression, restores T-cell activity, and supports anti-tumor therapy.

Adding disaccharides and sugar alcohols during reagent immobilization boosts RS virus immunoassay sensitivity by 1.5x or more.

Capillary flow changes in a cellulose-biomolecule paper chip enable rapid, specific PFAS detection without complex lab analysis.

Adjusting LRG composition to pH 7.8-9.0 with 300-600 mM sodium salt preserves protein stability for accurate quantitative measurement.

D-amino-acid CAIX peptide ligands improve stability and tumor penetration while enabling selective imaging and therapy of CAIX-expressing cancers.

Acidic tumor conditions activate EpCAM binding while neutral normal tissues see lower activity, helping improve efficacy and reduce side effects.

Fixed-ratio antibody combinations target distinct spike epitopes to strengthen neutralization of mutable SARS-CoV-2 variants in one composition.

Conventional markers can miss early epithelial carcinomas; CA-62 antibodies and chemiluminescence improve serum detection and treatment monitoring.

Closed-system TIL expansion and IP-10 support refractory melanoma treatment.

Microfiltration devices isolate tumor cells for fluorescence microscopy, reducing false positives in cancer diagnosis.

A meningioma-specific protein signature in blood serum detects tumors before radiological imaging identifies anatomical changes, enabling earlier diagnosis.

An antigen-binding molecule uses pH-dependent FcRn recycling to selectively clear protein aggregates from plasma.

Human monoclonal antibodies bind the thyroid stimulating hormone receptor to stimulate iodine uptake in thyroid cancer cells.

A VWF-free assay matrix with recombinant FVIII enables rapid inhibitor quantification in patient plasma samples.

IgM-multimerized single-domain antibodies form pentameric structures to bind ROR1 with high affinity and specificity.

An extracellular vesicle-based calibrator enables precise detection of circulating membrane-associated proteins like CD20 using specific capture antibodies.

Anti-CD300c monoclonal antibody targets CD300c on cancer cells to activate T cells, reducing adverse effects while inhibiting proliferation.

Amino acid mutations stabilize GPCRs against detergent denaturation, enabling crystallization of locked conformations.

A water-swelling membrane deforms to match lens curvature, resolving small contact area issues that invalidate safety tests.

Cysteine mutations in the FR1 region enable direct thiol grafting of nanobodies onto electrodes, resolving batch inconsistency and production delays.

Monoclonal antibody BC21 detects Uroplakin II protein to resolve the trade-off between broad isoform detection and specific measurement precision.